{"id":"https://openalex.org/W4401025199","doi":"https://doi.org/10.21518/ms2024-233","title":"Own experience of using combination therapy in the first line of treatment of metastatic renal cell carcinoma","display_name":"Own experience of using combination therapy in the first line of treatment of metastatic renal cell carcinoma","alternate_titles":[],"publication_year":2024,"publication_date":"2024-07-24","ids":{"openalex":"https://openalex.org/W4401025199","doi":"https://doi.org/10.21518/ms2024-233"},"language":"en","primary_location":{"id":"doi:10.21518/ms2024-233","doi":"https://doi.org/10.21518/ms2024-233","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21518/ms2024-233","pdf_url":"https://www.med-sovet.pro/jour/article/download/8399/7390","source":{"id":"https://openalex.org/S4210203888","display_name":"Meditsinskiy sovet = Medical Council","issn_l":"2079-701X","issn":["2079-701X","2658-5790"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4324034724","host_organization_name":"REMEDIUM GROUP LLC","host_organization_lineage":["https://openalex.org/P4324034724"],"host_organization_lineage_names":["REMEDIUM GROUP LLC"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Meditsinskiy sovet = Medical Council","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4401025199"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.med-sovet.pro/jour/article/download/8399/7390","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081116067","display_name":"\u0423\u0441\u0442\u0438\u043d\u043e\u0432\u0430 \u0422\u0430\u0442\u044c\u044f\u043d\u0430 \u0412\u0430\u0441\u0438\u043b\u044c\u0435\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0002-2061-0522","observed_orcids":["https://orcid.org/0000-0002-2061-0522"]},"institutions":[{"id":"https://openalex.org/I4210139937","display_name":"P.A. Hertzen Moscow Oncology Research Institute","ror":"https://ror.org/04rbazs75","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210139937"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"T. V. Ustinova","raw_affiliation_strings":["Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center"],"raw_orcid":"https://orcid.org/0000-0002-2061-0522","affiliations":[{"raw_affiliation_string":"Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center","institution_ids":["https://openalex.org/I4210139937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105103264","display_name":"A. Yu. Chanaeva","orcid":"https://orcid.org/0000-0001-5578-7515","observed_orcids":["https://orcid.org/0000-0001-5578-7515"]},"institutions":[{"id":"https://openalex.org/I4210139937","display_name":"P.A. Hertzen Moscow Oncology Research Institute","ror":"https://ror.org/04rbazs75","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210139937"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. Yu. Chanaeva","raw_affiliation_strings":["Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center"],"raw_orcid":"https://orcid.org/0000-0001-5578-7515","affiliations":[{"raw_affiliation_string":"Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center","institution_ids":["https://openalex.org/I4210139937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489136","display_name":"\u041f\u0430\u0439\u0447\u0430\u0434\u0437\u0435 \u0410\u043d\u043d\u0430 \u0410\u043b\u0435\u043a\u0441\u0430\u043d\u0434\u0440\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0001-7912-8055","observed_orcids":["https://orcid.org/0000-0001-7912-8055"]},"institutions":[{"id":"https://openalex.org/I4210139937","display_name":"P.A. Hertzen Moscow Oncology Research Institute","ror":"https://ror.org/04rbazs75","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210139937"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. A. Paichadze","raw_affiliation_strings":["Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center"],"raw_orcid":"https://orcid.org/0000-0001-7912-8055","affiliations":[{"raw_affiliation_string":"Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center","institution_ids":["https://openalex.org/I4210139937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020587798","display_name":"\u041b\u0435\u0432\u0448\u0430\u043a\u043e\u0432\u0430 \u0410\u043d\u0442\u043e\u043d\u0438\u043d\u0430 \u0412\u0430\u043b\u0435\u0440\u044c\u0435\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0002-2381-4213","observed_orcids":["https://orcid.org/0000-0002-2381-4213"]},"institutions":[{"id":"https://openalex.org/I4210139937","display_name":"P.A. Hertzen Moscow Oncology Research Institute","ror":"https://ror.org/04rbazs75","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210139937"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. V. Levshakova","raw_affiliation_strings":["Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center"],"raw_orcid":"https://orcid.org/0000-0002-2381-4213","affiliations":[{"raw_affiliation_string":"Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center","institution_ids":["https://openalex.org/I4210139937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026725606","display_name":"\u041b. \u0412. \u0411\u043e\u043b\u043e\u0442\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0003-4879-2687","observed_orcids":["https://orcid.org/0000-0003-4879-2687"]},"institutions":[{"id":"https://openalex.org/I4210139937","display_name":"P.A. Hertzen Moscow Oncology Research Institute","ror":"https://ror.org/04rbazs75","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210139937"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"L. V. Bolotina","raw_affiliation_strings":["Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center"],"raw_orcid":"https://orcid.org/0000-0003-4879-2687","affiliations":[{"raw_affiliation_string":"Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center","institution_ids":["https://openalex.org/I4210139937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064759318","display_name":"V. M. Ivanykina","orcid":"https://orcid.org/0009-0003-1169-102X","observed_orcids":["https://orcid.org/0009-0003-1169-102X"]},"institutions":[{"id":"https://openalex.org/I4210139937","display_name":"P.A. Hertzen Moscow Oncology Research Institute","ror":"https://ror.org/04rbazs75","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210139937"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. M. Ivanykina","raw_affiliation_strings":["Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center"],"raw_orcid":"https://orcid.org/0009-0003-1169-102X","affiliations":[{"raw_affiliation_string":"Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center","institution_ids":["https://openalex.org/I4210139937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052911447","display_name":"\u0410. \u0410. \u0424\u0435\u0434\u0435\u043d\u043a\u043e","orcid":"https://orcid.org/0000-0003-4927-5585","observed_orcids":["https://orcid.org/0000-0003-4927-5585"]},"institutions":[{"id":"https://openalex.org/I4210139937","display_name":"P.A. Hertzen Moscow Oncology Research Institute","ror":"https://ror.org/04rbazs75","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4210139937"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. A. Fedenko","raw_affiliation_strings":["Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center"],"raw_orcid":"https://orcid.org/0000-0003-4927-5585","affiliations":[{"raw_affiliation_string":"Hertsen Moscow Oncology Research Institute \u2013 Branch of the National Medical Research Radiological Center","institution_ids":["https://openalex.org/I4210139937"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210139937"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"10","first_page":"90","last_page":"96"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8560000061988831},{"id":"https://openalex.org/keywords/axitinib","display_name":"axitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.5559999942779541},{"id":"https://openalex.org/keywords/treatment-adverse-events","display_name":"treatment adverse events","score":0.4429999887943268},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.3790000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8649753332138062},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.8222936391830444},{"id":"https://openalex.org/C2776539811","wikidata":"https://www.wikidata.org/wiki/Q4830631","display_name":"Axitinib","level":4,"score":0.7612016201019287},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.7039246559143066},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6953275203704834},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5936253666877747},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5922445058822632},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5326699018478394},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5168593525886536},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.47081953287124634},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.439540833234787},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.4176221489906311},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.41702455282211304},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3378605544567108}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.21518/ms2024-233","doi":"https://doi.org/10.21518/ms2024-233","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21518/ms2024-233","pdf_url":"https://www.med-sovet.pro/jour/article/download/8399/7390","source":{"id":"https://openalex.org/S4210203888","display_name":"Meditsinskiy sovet = Medical Council","issn_l":"2079-701X","issn":["2079-701X","2658-5790"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4324034724","host_organization_name":"REMEDIUM GROUP LLC","host_organization_lineage":["https://openalex.org/P4324034724"],"host_organization_lineage_names":["REMEDIUM GROUP LLC"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Meditsinskiy sovet = Medical Council","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.21518/ms2024-233","doi":"https://doi.org/10.21518/ms2024-233","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21518/ms2024-233","pdf_url":"https://www.med-sovet.pro/jour/article/download/8399/7390","source":{"id":"https://openalex.org/S4210203888","display_name":"Meditsinskiy sovet = Medical Council","issn_l":"2079-701X","issn":["2079-701X","2658-5790"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4324034724","host_organization_name":"REMEDIUM GROUP LLC","host_organization_lineage":["https://openalex.org/P4324034724"],"host_organization_lineage_names":["REMEDIUM GROUP LLC"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Meditsinskiy sovet = Medical Council","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401025199.pdf","grobid_xml":"https://content.openalex.org/works/W4401025199.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1907173100","https://openalex.org/W1986141346","https://openalex.org/W2004630197","https://openalex.org/W2007070479","https://openalex.org/W2016278956","https://openalex.org/W2017322644","https://openalex.org/W2022007357","https://openalex.org/W2053353274","https://openalex.org/W2069204939","https://openalex.org/W2088571368","https://openalex.org/W2096322385","https://openalex.org/W2098005365","https://openalex.org/W2099752220","https://openalex.org/W2103689170","https://openalex.org/W2116949558","https://openalex.org/W2136490715","https://openalex.org/W2171469612","https://openalex.org/W2614480329","https://openalex.org/W2731516430","https://openalex.org/W2735460229","https://openalex.org/W2794002104","https://openalex.org/W2794419219","https://openalex.org/W2889646458","https://openalex.org/W2911812451","https://openalex.org/W2913745075","https://openalex.org/W2947878064","https://openalex.org/W2967590894","https://openalex.org/W3093923068","https://openalex.org/W3100229235","https://openalex.org/W3188821663","https://openalex.org/W4205647613","https://openalex.org/W4255387133"],"related_works":["https://openalex.org/W4285493466","https://openalex.org/W2922408898","https://openalex.org/W3100020531","https://openalex.org/W4388894652","https://openalex.org/W3049325142","https://openalex.org/W3003186211","https://openalex.org/W3194226201","https://openalex.org/W3091396150","https://openalex.org/W4390973549","https://openalex.org/W2968102433"],"abstract_inverted_index":{"Renal":[0],"cell":[1,18,111,121,148,205],"carcinoma":[2,19,122],"is":[3,21,26],"one":[4],"of":[5,16,30,35,40,66,83,93,108,119,133,136,145,152,169,176,179,190,193,200],"the":[6,22,33,64,81,106,117,124,127,143,166,174,188,191,198],"most":[7],"common":[8],"diseases":[9],"in":[10,28,105,116,130,197],"oncourology.":[11],"The":[12,91,113],"leading":[13],"morphological":[14],"variation":[15],"renal":[17,110,120,147,204],"today":[20],"light-cell":[23],"subtype,":[24],"which":[25,51,161],"determined":[27],"80%":[29],"cases.":[31],"Despite":[32],"intensity":[34],"diagnostic":[36],"methods,":[37],"almost":[38],"1/3":[39],"patients":[41,201],"with":[42,63,156,202],"kidney":[43],"cancer":[44],"have":[45],"distant":[46],"metastases":[47],"during":[48],"initial":[49],"examination,":[50],"causes":[52],"extremely":[53],"high":[54],"mortality":[55],"rates":[56],"from":[57],"this":[58],"oncopathology.":[59],"Standard":[60],"chemotherapy":[61],"schemes":[62],"inclusion":[65],"fluoropyrimidines":[67],"and":[68,75,140,195],"antitumor":[69,180],"antibiotics,":[70],"cytokine":[71],"therapy":[72],"using":[73],"interleukin-2":[74],"interferon":[76],"\u03b1":[77],"only":[78,163],"slightly":[79],"prolonged":[80],"life":[82,167],"patients,":[84,170],"while":[85],"causing":[86],"pronounced":[87],"toxic-anemic":[88],"adverse":[89,177],"events.":[90],"appearance":[92],"tyrosine":[94],"kinase":[95],"inhibitors":[96,155],"has":[97],"allowed":[98],"us":[99],"to":[100],"obtain":[101],"really":[102],"significant":[103],"results":[104],"treatment":[107,118,144,199],"metastatic":[109,146,203],"carcinoma.":[112,149,206],"next":[114],"step":[115],"was":[123],"registration":[125],"by":[126],"US":[128],"FDA":[129],"April":[131],"2018":[132],"a":[134],"combination":[135,192],"immuno-oncological":[137],"drugs":[138,158],"ipilimumab":[139],"nivolumab":[141],"for":[142],"Afterwards,":[150],"combinations":[151],"immune":[153],"checkpoint":[154],"targeted":[157],"were":[159],"registered,":[160],"not":[162],"significantly":[164],"increased":[165],"expectancy":[168],"but":[171],"also":[172],"reduced":[173],"incidence":[175],"events":[178],"therapy.":[181],"This":[182],"article":[183],"provides":[184],"clinical":[185],"examples":[186],"demonstrating":[187],"effectiveness":[189],"pembrolizumab":[194],"axitinib":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4401025199","counts_by_year":[],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2024-07-27T00:00:00"}
